Specific cellular immune response and cytokine patterns in patients coinfected with hepatitis C viru - PowerPoint PPT Presentation

1 / 30
About This Presentation
Title:

Specific cellular immune response and cytokine patterns in patients coinfected with hepatitis C viru

Description:

History of schistosomiasis. Detection of S. mansoni ova in stool or rectal biopsy. ... The samples were read in a blinded fashion. ... – PowerPoint PPT presentation

Number of Views:123
Avg rating:3.0/5.0
Slides: 31
Provided by: kalifam
Category:

less

Transcript and Presenter's Notes

Title: Specific cellular immune response and cytokine patterns in patients coinfected with hepatitis C viru


1
Specific cellular immune response and cytokine
patterns in patients coinfected with hepatitis C
virus and Schistosoma mansoni
2
SANAA M. KAMAL, LEONARDO BIANCHI, AHMED AL
TAWIL, MARGARET KOZIEL, KHALIFA EL SAYED KHALIFA,
THOMAS PETER, and JENS W. RASENACK,
3
  • Schistosomiasis and HCV coinfection is common in
    Egypt
  • Patients coinfected with HCV and schistosomiasis
    exhibit a unique clinical virological and
    histological pattern manifested by viral
    persistence with high HCV RNA titers, as well as
    higher necro-inflammatory and fibrosis scores in
    their liver biopsy samples.

4
AIM OF THE WORK
5
  • The study was done to investigate the influence
    of S. mansoni on the HCV-specific cellular
    immune response by
  • Proliferative response of peripheral blood
    mononuclear cells (PBMCs) to HCV and
    schistosomal. antigens.
  • Determination of proliferative response cells
    subtypes.
  • Cytokines (TNF-?, INF-?, IL-4, IL-10) production
    by PBMCs in response to HCV and schistosomal.
    antigens.
  • Cytokines levels in the patients sera.
  • Correlations between the proliferative response
    and cytokines production and the
    necroinflammatory changes in the liver.

6
  • MATERIALS AND METHODS

7
PATINETS
  • The study was done on 85 patients and 10 health
    control subjects
  • Group A 30 patients chronically infected with
    HCV
  • Seropositive for HCV antibody.
  • Positive for HCV RNA by PCR.
  • Elevated ALT and AST for more than 6 months.
  • Liver biopsy showing evidence of chronic
    hepatitis.

8
PATINETS
  • Group B included 20 patients infected with
    schistosomiasis alone.
  • History of schistosomiasis.
  • Detection of S. mansoni ova in stool or rectal
    biopsy.
  • Seropositivty for schistosomal antibodies by
    Indirect Haemagglution Assay (IHA)
  • Group C included 35 patients with chronic HCV
    and S. mansoni coinfection. All the patients
    acquired schistosomiasis before HCV.

9
Antigens and Mitogens
  • HCV antigens
  • purified recombinant core antigen, nonstructural
    antigen (NS) 3, 4 and 5
  • Soluble egg antigen (SEA)
  • Soluble adult worm antigen protein (SWAP).
  • Non-specific control positive antigens
    Phytohemagglutinin (PHA) and tetanus toxoid.
  • Negative control antigen
  • superoxide dismutase (SOD)

10
Proliferation Assay
  • PBMCs from patients and control subjects were
    isolated and cultured in triplicates in 96well
    plates in the presence of HCV proteins (10
    µg/ml), schistosomal antigens (15-50 µg/ml), PHA
    (1/200 dilution) and SOD as a negative or no
    stimulation control. Cultures were incubated at
    37?C for 5 days in a humidified atmosphere with
    5 Co2.
  • The amount of 3H-thymidine incorporated by
    cells was determined by liquid scintillation
    counting. Results were expressed as the
    stimulation index
  • SI counts per minute incorporated (cpm) in
    response to antigen/cpm incorporated in the
    absence of the antigen.
  • SI exceeding 3 SD above the mean SI of healthy
    control subjects was considered positive.

11
Determination of Cell Subtypes
  • Determination of CD4 and CD8 subtypes was
    performed by using flow cytometry after staining
    of the cells with isothiocynate-labeled anti-CD4
    and anti-CD8 antibodies.
  • Cells cultured with the respective antigen or
    mitogen were incubated for 30 minutes with 2
    µg/ml of the monoclonal antibodies, washed twice
    with cold PBS and then analyzed by flow cytometry
    in a fluorescent activated cell sorter.

12
Cytokines Measurement
  • 48 hours supernatants of mitogen or antigen-
    stimulated PBMCs were collected.
  • Sera form the three groups under study were
    collected.
  • The supernatants and sera were stored at 85?C
    until assayed for TNF-?, INF-?, IL-4, IL-10 using
    commercial ELISA Kits according to the
    manufacturers instructions.

13
Histological Assessment
  • Liver biopsy samples were stained with H and E
    and a connective tissue stain.
  • The samples were read in a blinded fashion.
    Necroinflammatory changes were graded with a
    staging score of 0 - 18. Fibrosis was evaluated
    with a staging score of 0 - 6.
  • The correlation between the proliferative
    response and cytokines production, and the
    necroinflammatory changes and fibrosis of the
    liver were studied.

14
RESULTS
15
Demographic and baseline characteristics of
patients with HCV or/and S. mansoni
16
Percentages of proliferative PBMCs, from the
groups under study, in response to HCV proteins,
schistosomal antigens and PHA
17
Stimulation indices of proliferative PBMCs, from
the groups under study, in response to HCV
proteins, schistosomal antigens and PHA
18
Relation of HCV specific CD4 proliferative
response to HCV RNA virus load
19
INF-? production by PBMCs, from the groups under
study, in response to HCV proteins, schistosomal
antigens and PHA
20
TNF-? production by PBMCs, from the groups under
study, in response to HCV proteins, schistosomal
antigens and PHA
21
IL-4 production by PBMCs, from the groups under
study, in response to HCV proteins, schistosomal
antigens and PHA
22
IL-10 production by PBMCs, from the groups under
study, in response to HCV proteins, schistosomal
antigens and PHA
23
Cytokines levels in the sera of the patients
groups (A, B, C) and control subjects (N)
24
Correlation between cytokines, and
necroinflammatory and fibrosis scores
25
CONCLUSION
26
  • Coinfected patients showed significant
    qualitative and quantitative suppressed cellular
    response to HCV antigens, when compared to
    patients with HCV alone.
  • Coinfected patients mounted strong qualitative
    and quantitative cellular response to SEA and
    SWAP that was not significantly different from
    the responses in patients infected with S.
    mansoni alone.
  • Study of the cell subtypes showed that the
    proliferative response was of CD4 subtype

27
  • Patients showing positive HCV-specific cellular
    responses had lower mean virus load.
  • PBMCs stimulation with HCV antigen produced a
    type 1 cytokines (INF-? and TNF-?) profiles in
    patinets infected with HCV alone, compared with a
    type 2 (IL-4 and IL-10) predominance in patients
    coinfected with HCV and S. mansoni.
  • On the other hand, stimulation of PBMCs with SEA
    and SWAP resulted in a predominant type 2
    cytokines profile (IL-4 and IL-10) in coinfected
    and isolated S. mansoni infected patinets.

28
  • Sera of patients with isolated HCV infection
    showed type 1 cytokines profile compared with a
    type 2 predominance in patients coinfected with
    HCV and S. mansoni.
  • A significant correlation was found between
    TNF-? and the necroinflammatory scores in
    patients with isolated HCV infection, such
    correlation was not apparent among Coinfected and
    Isolated S. mansoni infected patients.
  • On the other hand, there was a significant direct
    correlation between IL-4 levels and the
    fibrosis/cirrhosis score and an inverse
    correlation between INF-? levels and
    fibrosis/cirrhosis score.

29
  • These findings demonstrate that the inability to
    mount an HCV-specific CD4/Th1 cell response
    plays a role in the persistence and severity of
    HCV infection in patients with S. mansoni
    coinfection

30
THANK YOU
Write a Comment
User Comments (0)
About PowerShow.com